Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: Meta-regression of randomized trials

Contemporary Clinical Trials

Volumn 38, Issue 1, 2014, Pages 51-58

  D'Ascenzo, Fabrizio ^a   Barbero, Umberto ^a   Moretti, Claudio ^a   Palmerini, Tullio ^b   Della Riva, Diego ^b   Mariani, Andrea ^b   Omedè, Pierluigi ^a   DiNicolantonio, James J ^e   Biondi Zoccai, Giuseppe ^c,d,f   Gaita, Fiorenzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Department of Medico Surgical Sciences and Biotechnologies ^*  (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^f Meta analysis and Evidence based medicine Training in Cardiology   (Italy)

Author keywords

CABG; Meta regression; PCI; Stroke

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; FOLLOW UP; HUMAN; META ANALYSIS (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; STABLE ANGINA PECTORIS; SYSTEMATIC REVIEW (TOPIC); AGE; ANGINA, STABLE; HEART STROKE VOLUME; META ANALYSIS; MYOCARDIAL INFARCTION; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; ANGINA, STABLE; CORONARY ARTERY BYPASS; DIABETES MELLITUS; HUMANS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEX FACTORS; STROKE; STROKE VOLUME;

EID: 84897434562     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2014.03.002     Document Type: Article

References (53)

1. De Bruyne B., Pijls N.H., Kalesan B., Barbato E., Tonino P.A., Piroth Z., et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012, 367:991-1001.
2. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N Engl J Med 1984, 310750-310758. [No authors listed].
3. Morrison D.A., Sethi G., Sacks J., Grover F., Sedlis S., Esposito R., et al. A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans Affairs. Control Clin Trials 1999, 20:601-619.
4. Capodanno D., Stone G.W., Morice M.C., Bass T.A., Tamburino C. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. J Am Coll Cardiol 2011, 58:1426-1432.
5. Kappetein A.P., Feldman T.E., Mack M.J., Morice M.C., Holmes D.R., Ståhle E., et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011, 32:2125-2134.
6. Onuma Y., Wykrzykowska J.J., Garg S., Vranckx P., Serruys P.W., ARTS I and II Investigators 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials. JACC Cardiovasc Interv 2011, 4:317-323.
7. Palmerini T., Biondi-Zoccai G., Reggiani L.B., Sangiorgi D., Alessi L., De Servi S., et al. Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention. J Am Coll Cardiol 2012, 60:798-805.
8. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2011/07/WC500109477.pdf.
9. Steg P.G., Greenlaw N., Tardif J.C., Tendera M., Ford I., Kääb S., et al. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J 2012, 26.
10. Zhang Z., Weintraub W.S., Mahoney E.M., Spertus J.A., Booth J., Nugara F., et al. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial). Am J Cardiol 2004, 93:404-409.
11. Sato H., Kasai T., Miyauchi K., Kubota N., Kajimoto K., Miyazaki T., et al. Long-term outcomes of women with coronary artery disease following complete coronary revascularization. J Cardiol 2011, 58:158-164.
12. D'Ascenzo F., Gonella A., Quadri G., Longo G., Biondi-Zoccai G., Moretti C., et al. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction. Am J Cardiol 2011, 107:651-654.
13. Weintraub W.S., Grau-Sepulveda M.V., Weiss J.M., O'Brien S.M., Peterson E.D., Kolm P., et al. Comparative effectiveness of revascularization strategies. N Engl J Med 2012, 19(366):1467-1476.
14. Kirschbaum S.W., Springeling T., Boersma E., Moelker A., van der Giessen W.J., Serruys P.W., et al. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging. JACC Cardiovasc Interv 2010, 3:392-400.
15. Hee L., Mussap C.J., Yang L., Dignan R., Kadappu K.K., Juergens C.P., et al. Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease. Am J Cardiol 2012, 110:643-648.
16. Hlatky M.A., Boothroyd D.B., Bravata D.M., Boersma E., Booth J., Brooks M.M., et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009, 4(373):1190-1197.
17. http://riskcalc.sts.org/STSWebRiskCalc273/.
18. http://www.euroscore.org/.
19. Moher D., Liberati A., Tetzlaff J., PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 21:339-341.
20. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999, 354:1896-1900.
21. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration 2009, [Available from www.cochrane-handbook.org]. J.P.T. Higgins, S. Green (Eds.).
22. Wallace Byron C., Schmid Christopher H., Lau Joseph, Trikalinos Thomas A. Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 2009, 9(1):80.
23. The Cochrane Collaboration: RevMan 4.2 User Guide 2005, The Cochrane Collaboration, Oxford, [http://www.cc-ims.net/RevMan/documentation.htm].
24. Singh M., Rihal C.S., Gersh B.J., et al. Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience. Circulation 2007, 115:2835-2841.
25. Singh M., Rihal C.S., Gersh B.J., et al. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol 2008, 51:2313-2320.
26. Hilliard A.A., From A.M., Lennon R.J., et al. Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents. J Am Coll Cardiol Intv 2010, 3:172-179.
27. Bakhai A., Hill R.A., Dundar Y., et al. Percutaneous coronary intervention with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes. Cochrane Database Syst Rev 2005, CD004588.
28. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993, 341:573-580.
29. Hamm C.W., Reimers J., Ischinger T., et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 1994, 331:1037-1043.
30. King S.B., Lembo N.J., Weintraub W.S., et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 1994, 331:1044-1050.
31. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996, 335:217-225.
32. Serruys P.W., Unger F., Sousa J.E., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001, 344:1117-1124.
33. Rosenberg M.S. The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis. Int J Org Evol 2005, 59:464-468.
34. Hueb W.A., Bellotti G., de Oliveira S.A., et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995, 26:1600-1605.
35. Hueb W., Lopes N.H., Gersh B.J., et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007, 115:1082-1089.
36. Yousef Z.R., Redwood S.R., Bucknall C.A., et al. Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol 2002, 40:869-876.
37. Steg P.G., Thuaire C., Himbert D., et al. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J 2004, 25:2187-2194.
38. Bravata D.M., Gienger A.L., McDonald K.M., et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. Ann Intern Med 2007, 147:703-716.
39. Roach G.W., Kanchuger M., Mangano C.M., for the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996, 335:1857-1863.
40. Stamou S.C., Hill P.C., Dangas G., et al. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 2001, 32:1508-1513.
41. Hoffman S.J., Routledge H.C., Lennon R.J., et al. Procedural factors associated with percutaneous coronary intervention-related ischemic stroke. J Am Coll Cardiol Interv 2012, 5:200-206.
42. Solomon N.A., Glick H.A., Russo C.J., Lee J., Schulman K.A. Patient preferences for stroke outcomes. Stroke 1994, 25:1721-1725.
43. D'Ancona G., de Ibarra JI Saez, Baillot R., Mathieu P., Doyle D., Metras J., et al. Determinants of stroke after coronary artery bypass grafting. Eur J Cardiothorac Surg 2003, 2:552-556.
44. Charlesworth D.C., Likosky D.S., Marrin C.A., Maloney C.T., Quinton H.B., Morton J.R., et al. Development and validation of a prediction model for strokes after coronary artery bypass grafting. Ann Thorac Surg 2003, 76:436-443. [20].
45. John R., Choudhri A.F., Weinberg A.D., Ting W., Rose E.A., Smith C.R., et al. Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg 2000, 69:30-35.
46. Hogue C.W., Murphy S.F., Schechtman K.B., vila-Roman V.G. Risk factors for early or delayed stroke after cardiac surgery. Circulation 1999, 100:642-647.
47. Alam M., et al. Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis. Int J Cardiol 2012, 167(1):180-184.
48. Eifert S., Kilian E., Beiras-Fernandez A., et al. Early and mid term mortality after coronary artery bypass grafting in women depends on the surgical protocol: retrospective analysis of 3441 on- and off-pump coronary artery bypass grafting procedures. J Cardiothorac Surg 2010, 5:90.
49. Ben-Gal Y., Moshkovitz Y., Nesher N., Uretzky G., Braunstein R., Hendler A., et al. Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Ann Thorac Surg 2006, 82:1692-1697.
50. Wijns W., Kolh P., Danchin N., for the The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), et al. Guidelines on myocardial revascularization. Eur Heart J 2010, 31:2501-2555.
51. Stefanini G.G., Kalesan B., Pilgrim T., Raber L., Onuma Y., Silber S., et al. Impact of gender on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv 2012, 5(3):301-310.
52. Quadri G., D'ascenzo F., Bollati M., Moretti C., Omedé P., Sciuto F., et al. Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention. Acta Cardiol Apr 2013, 68(2):151-160.
53. Berlin J.A., Antman E.M. Advantages and limitations of metaanalytic regressions of clinical trials data. Online J Curr Clin Trials Jun 4 1994, 1-3. [Doc No 134].